丹蛭降糖胶囊治疗气阴两虚夹瘀型非增殖期糖尿病视网膜病变的临床观察及机制研究.docxVIP

  • 1
  • 0
  • 约4.41千字
  • 约 7页
  • 2026-03-09 发布于北京
  • 举报

丹蛭降糖胶囊治疗气阴两虚夹瘀型非增殖期糖尿病视网膜病变的临床观察及机制研究.docx

丹蛭降糖胶囊治疗气阴两虚夹瘀型非增殖期糖尿病视网膜病变的临床观察及机制研究

关键词:丹蛭降糖胶囊;气阴两虚夹瘀型;非增殖期糖尿病视网膜病变;临床观察;机制研究

Abstract:ThisstudyaimstoexplorethetherapeuticeffectofDanbiJiangtangCapsulesonnon-proliferativediabeticretinopathywithQiandYindeficiencyandbloodstasisinpatientswithnon-proliferativediabetesmellitus.Arandomizedcontrolledtrialwasconducted,selectingacertainnumberofpatientswithnon-proliferativediabeticretinopathywithQiandYindeficiencyandbloodstasisasresearchsubjects.Thesubjectswererandomlydividedintocontrolgroupandexperimentalgroup,thecontrolgroupreceivedroutinetreatment,whiletheexperimentalgroupwasgivenDanbiJiangtangCapsulestreatmentontopoftheroutinetreatment.Afteraperiodoftreatment,thetherapeuticeffects,bloodglucosecontrol,andimprovementofdiabeticretinopathyintheexperimentalgroupwerecomparedwiththoseinthecontrolgroup.Themechanismofactionwaspreliminarilyexplored.TheresultsshowedthatDanbiJiangtangCapsulescouldeffectivelyreducebloodglucoselevels,improveclinicalsymptomsofnon-proliferativediabeticretinopathywithQiandYindeficiencyandbloodstasis,promotetherepairofdiabeticretinopathy,anditsmechanismmayberelatedtotheregulationofimmunefunction,improvementofmicrocirculation,andantioxidantproperties.Thisstudyprovidesnewideasandmethodsforthetreatmentofnon-proliferativediabeticretinopathywithQiandYindeficiencyandbloodstasis.

Keywords:DanbiJiangtangCapsules;QiandYindeficiencyandbloodstasis;Non-proliferativediabeticretinopathy;Clinicalobservation;Mechanismstudy

第一章引言

1.1糖尿病视网膜病变概述

糖尿病视网膜病变是糖尿病最常见的并发症之一,它不仅影响视力,还可能导致失明。该病的发生与高血糖状态密切相关,长期高血糖可导致微血管损伤、血液流变学改变、细胞外基质异常沉积等病理变化,最终引发视网膜出血、水肿、新生血管形成等病变。非增殖期糖尿病视网膜病变是糖尿病视网膜病变的一种类型,通常不伴有明显的视网膜增厚或玻璃体出血,但存在视网膜微血管的异常扩张和渗漏,且病情进展缓慢。因此,早期诊断和治疗对于预防或延缓非增殖期糖尿病视网膜病变的发展至关重要。

1.2糖尿病视网膜病变的分类

糖尿病视网膜病变根据病程的不同可分为急性和慢性两种类型。急性糖尿病视网膜病变通常发生在病程较短的糖尿病患者中,病变进展迅速,常伴有视网膜出血和渗出。而慢

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档